Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients

NCT01481805 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01481805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01481805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
January 14, 2010
Completion date
August 13, 2014
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma